Science and Technology Innovation Program
The first edition of the Synthetic Biology Newsletter, published in November 2010, reviews the basics of synthetic biology, explains how this new emerging technology intersects with several areas of science and talks about its effect on public perception.
The Wilson Center's Project on Emerging Nanotechnologies released a report by one of the country's foremost authorities on environmental research and policy, J. Clarence Davies, which examines the strengths and weaknesses of the current regulatory framework for nanotechnology and calls for a new approach to nanotechnology oversight.
Scientists talk about the convergence of nanotechnology, biotechnology, information technology and cognitive science in this collection of exclusive interviews produced by the Science & Technology Innovation Program in conjunction with the National Science Foundation.
A new report released today, Regulating the Products of Nanotechnology: Does FDA Have the Tools It Needs? by Michael Taylor, a former Deputy Commissioner for Policy at the Food and Drug Administration (FDA), examines the agency's capacity to properly regulate new products containing nanotechnology materials—including food, drugs, medical devices, dietary supplements and cosmetics.